efgartigimodrecombinant human hyaluronidase PH20rHuPH20PH20 SCHealth Assessment QuestionnaireSystemic SclerosisSystemic sclerosis (SSc)NCT06655155interstitial lung disease
…SSc will be randomized 2:1 to receive weekly administrations of efgartigimod or placebo PH20 SC (coformulated with recombinant human hyaluro…